1477 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Aghajanian
    Aghajanian
  4. O'Reilly
    O'Reilly
  5. Kris
    Kris
  6. Scher
    Scher
  7. Panageas
    Panageas
  8. Saltz
    Saltz
  9. Schwartz
    Schwartz
  10. Kelsen
    Kelsen

Groups

  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)
  7. Epidemiology and Biostatistics (194)
  8. Biostatistics Service (169)
  9. Gastrointestinal Oncology Service (160)
  10. Population Sciences Research Program (158)
  1. "fatigue"
Formats
  1. Journal Article (1402)
  2. Review (38)
  3. Research Letter (13)
  4. Editorial (10)
  5. Conference Paper (5)
  6. Guidelines (4)
  7. Correspondence (3)
  8. Book Section (2)
Groups
  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)

More Groups

People
  1. Robert Motzer (85)
  2. Clifford Hudis (49)
  3. Carol Aghajanian (46)
  4. Eileen O'Reilly (46)
  5. Howard Scher (44)
  6. Mark Kris (44)

More People

Years
  1. 2025 (60)
  2. 2024 (132)
  3. 2023 (89)
  4. 2022 (46)
  5. 2021 (33)
  6. 2020 (85)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Clinical Cancer Research (82)
  3. Cancer (63)
  4. Lancet Oncology (50)
  5. Gynecologic Oncology (41)
  6. Annals of Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (244)
  2. Springer (133)
  3. American Society of Clinical Oncology (114)
  4. Elsevier Science, Inc. (108)
  5. Oxford University Press (101)
  6. American Association for Cancer Research (89)

More Publishers

Results (1477)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial
    Journal Article

    Gupta, A.; O'Cearbhaill, R. E.; Block, M. S.; Hamilton, E.; Konner, J. A.; Knutson, K. L.; Potts, J.; Garrett, G.; Kenney, R. T.; Wenham, R. M.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: The phase III SPINET study
    Journal Article

    Baudin, E.; Capdevila, J.; Hörsch, D.; Singh, S.; Caplin, M. E.; Wolin, E. M.; Buikhuisen, W.; Raderer, M.; Dansin, E.; Grohe, C.; more...
    Endocrine-Related Cancer (2024)

    Fulltext@MSK | Save
  • Evaluating immune checkpoint blockade in metastatic castration-resistant prostate cancers with deleterious CDK12 alterations in the phase 2 IMPACT trial
    Journal Article

    Nguyen, C. B.; Reimers, M. A.; Perera, C.; Abida, W.; Chou, J.; Feng, F. Y.; Antonarakis, E. S.; McKay, R. R.; Pachynski, R. K.; Zhang, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Acupuncture for fatigue in breast cancer survivors: A study protocol for a pragmatic, mixed method, randomised controlled trial
    Journal Article

    Alræk, T.; Skjerve, H.; Sørensen, A.; Lie, S. A.; Presterud Ødegård, H.; Lu, W.; Mao, J.; Deng, G.; Lee, M. S.; Birch, S.; more...
    BMJ Open (2024)

    Fulltext@MSK | Save
  • Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results
    Journal Article

    Cortes, J. E.; Sasaki, K.; Kim, D. W.; Hughes, T. P.; Etienne, G.; Mauro, M. J.; Hochhaus, A.; Lang, F.; Heinrich, M. C.; Breccia, M.; more...
    Leukemia (2024)

    Fulltext@MSK | Save
  • Concurrent validity of PROMIS and LD-SRS scores in pediatric patients with lower limb differences
    Journal Article

    Sabharwal, S.; Coufal, S.; Less, J.; Sabharwal, S.
    Journal of Pediatric Orthopaedics (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of regorafenib as a first-line agent alone or in combination with an immune checkpoint inhibitor for advanced hepatocellular carcinoma: A retrospective cohort study
    Journal Article

    Yu, J.; Bai, Y.; Cui, Z.; Cheng, C.; Ladekarl, M.; Cheng, K. C.; Chan, K. S.; Yarmohammadi, H.; Mauriz, J. L.; Zhang, Y.
    Journal of Gastrointestinal Oncology (2024)

    Fulltext@MSK | Save
  • A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR)
    Journal Article

    Ahluwalia, M. S.; Peereboom, D. M.; Ozair, A.; Khosla, A. A.; Ozair, A.; Rudek, M.; Ye, X.; Holdhoff, M.; Grossman, S. A.; Ye, X.; more...
    Cell Reports Medicine (2024)

    Fulltext@MSK | Save
  • Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: Final analysis of clinically relevant subgroups in GRIFFIN
    Journal Article

    Chari, A.; Kaufman, J. L.; Laubach, J.; Sborov, D. W.; Reeves, B.; Rodriguez, C.; Silbermann, R.; Costa, L. J.; Anderson, L. D.; Nathwani, N.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Patient-reported outcomes as a recruitment strategy for clinical trial enrollment
    Journal Article

    Verdini, N. P.; Bryl, K. L.; Baser, R. E.; Lapen, K.; Mao, J. J.; Gillespie, E. F.
    JAMA Oncology (2024)

    Fulltext@MSK | Save